Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272219
Max Phase: Preclinical
Molecular Formula: C16H11ClO3
Molecular Weight: 286.71
Associated Items:
ID: ALA5272219
Max Phase: Preclinical
Molecular Formula: C16H11ClO3
Molecular Weight: 286.71
Associated Items:
Canonical SMILES: CC(=O)c1cc2cc(-c3cccc(Cl)c3)oc2cc1O
Standard InChI: InChI=1S/C16H11ClO3/c1-9(18)13-6-11-7-15(20-16(11)8-14(13)19)10-3-2-4-12(17)5-10/h2-8,19H,1H3
Standard InChI Key: KFKQYYRKLORISV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 286.71 | Molecular Weight (Monoisotopic): 286.0397 | AlogP: 4.66 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.40 | CX Basic pKa: | CX LogP: 4.21 | CX LogD: 4.17 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.70 | Np Likeness Score: 0.02 |
1. Kousaxidis A, Petrou A, Lavrentaki V, Fesatidou M, Nicolaou I, Geronikaki A.. (2020) Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus., 207 [PMID:32871344] [10.1016/j.ejmech.2020.112742] |
Source(1):